Stay updated on EDP1503 in CRC, Breast Cancer & Checkpoint Inhibitor Failure Clinical Trial
Sign up to get notified when there's something new on the EDP1503 in CRC, Breast Cancer & Checkpoint Inhibitor Failure Clinical Trial page.

Latest updates to the EDP1503 in CRC, Breast Cancer & Checkpoint Inhibitor Failure Clinical Trial page
- Check5 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check12 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check19 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check26 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check55 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check62 days agoChange DetectedThe webpage has undergone significant updates regarding a clinical study involving EDP1503 and pembrolizumab, including changes to the study's description, patient cohorts, and collaborators. Notably, the previous version's detailed inclusion and exclusion criteria have been removed.SummaryDifference43%
Stay in the know with updates to EDP1503 in CRC, Breast Cancer & Checkpoint Inhibitor Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EDP1503 in CRC, Breast Cancer & Checkpoint Inhibitor Failure Clinical Trial page.